The Global Intracranial Aneurysm Market Size accounted for USD 1,216 Million in 2021 and is estimated to achieve a market size of USD 2,631 Million by 2030 growing at a CAGR of 9.2% from 2022 to 2030. The intracranial aneurysm market revenue can be attributable to technical advancements in healthcare facilities, rising government expenditure, and an increase in the number of occurrences of brain aneurysms. Furthermore, an increase in incidences of hypertension & brain aneurysms as the global elderly population grows, as well as expanding use of invasive procedures intracranial aneurysm operations, is expected to propel the intracranial aneurysm market growth in the upcoming decades.
Intracranial Aneurysm Market Report Key Highlights
An intracranial aneurysm is a cerebrovascular disorder caused due to weakness in the wall of a cerebral artery or vein and results in dilation or ballooning of the blood vessel. The other names of the disorder include cerebral aneurysm, brain aneurism, brain aneurysm, a cerebral aneurism. Additionally, the treatment includes endovascular coiling, surgical clipping, and cerebral bypass surgery. It causes Hypertension, infection, and head trauma. Moreover, the symptoms of the disorder include severe headache, visual problems, nausea and vomiting, and confusion.
Global Intracranial Aneurysm Market Dynamics
Intracranial Aneurysm Market Report Coverage
|Market||Intracranial Aneurysm Market|
|Intracranial Aneurysm Market Size 2021||USD 1,216 Million|
|Intracranial Aneurysm Market Forecast 2030||USD 2,631 Million|
|Intracranial Aneurysm Market CAGR During 2022 - 2030||9.2%|
|Intracranial Aneurysm Market Analysis Period
||2018 - 2030|
|Intracranial Aneurysm Market Base Year||2021|
|Intracranial Aneurysm Market Forecast Data||2022 - 2030|
|Segments Covered||By Type, By End-Use, And By Geography
|Regional Scope||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa|
|Key Companies Profiled||B. Braun, Codman Neuro (Integra Lifesciences), Johnson and Johnson Services Inc., Medtronic plc, Microport Scientific Corporation, MicroVention Inc. (Terumo Corporation), RAUMEDIC AG, and Stryker Corporation.|
||Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis|
The rising prevalence of brain aneurysms along with the introduction of technologically advanced products in the market is driving the market growth. The rising demand for minimally invasive procedures across the globe along with the increased spending on healthcare solutions is supporting the market growth. The rising research and development activities by major players as well as government authorities are further proliferating the market value. Furthermore, ongoing efforts for the development of cost-effective solutions and rising awareness about the treatment are projected to create potential opportunities over the forecast period from 2022 to 2030.
On the other hand, the high cost associated with the treatment as well as strict government regulations, are likely to hinder the growth over the forecast period from 2022 to 2030.
Intracranial Aneurysm Market Segmentation
The worldwide intracranial aneurysm market segmentation is based on the type, end-use, and geography.
Intracranial Aneurysm Market By Type
According to the intracranial aneurysm industry analysis, the endovascular coiling segment has registered the highest market share in 2021. The increasing demand for minimally invasive techniques in the global market is supporting the segmental market value. Endovascular coiling refers to the minimally invasive technique which means a catheter is used to reach the aneurysm in the brain, instead of making an incision in the brain. Additionally, a catheter is passed through the groin up into the artery containing the aneurysm.
Intracranial Aneurysm Market By End-use
According to the intracranial aneurysm market forecast, hospitals and clinics are the leading category in the global market and are expected to grow significantly in the coming years. The availability of technologically advanced infrastructure and trained professionals are supporting the segmental market value. The increasing number of hospitals in the global market, particularly in developing economies across the globe is majorly contributing to the segmental market value during the forecast timeframe from 2022 to 2030.
Intracranial Aneurysm Market Regional Outlook
The Middle East & Africa (MEA)
North America accounted for the maximum revenue share in the Intracranial Aneurysm Market
In 2021, North America has registered maximum revenue share in the intracranial aneurysm market and the region is also projected to maintain its dominance over the forecast timeframe from 2022 to 2030. The presence of major global players in the region is supporting the regional market value. The major economies of the region including the US and Canada are the major revenue contributors in 2021. The continuous technological advancements in the product offerings of the major players as well as the presence of a high-income population base in the regional market are boosting the regional market value.
Intracranial Aneurysm Market Players
Some of the top Intracranial Aneurysm market companies offered in the professional report include B. Braun, Codman Neuro (Integra Lifesciences), Johnson and Johnson Services Inc., Medtronic plc, Microport Scientific Corporation, MicroVention Inc. (Terumo Corporation), RAUMEDIC AG, and Stryker Corporation.
BIOMODEX, a pioneering digital health company that offers a unique and enhanced 3D printed solution for patient-specific rehearsal and physician training. The company has announced the presentation of data at SFNR 2020 highlighting the benefits of patient-specific rehearsals in complex unruptured intracranial aneurysms and the company's EVIAS™ (EndoVascular Intracranial Aneurysm System) solution was the focus of the ppt.
The estimated value of global intracranial aneurysm market in 2021 was accounted to be USD 1,216 Million.
The projected CAGR intracranial aneurysm market during the analysis period of 2022 to 2030 is 9.2%.
The prominent players of the global intracranial aneurysm market are B. Braun, Codman Neuro (Integra Lifesciences), Johnson and Johnson Services Inc., Medtronic plc, Microport Scientific Corporation, MicroVention Inc. (Terumo Corporation), RAUMEDIC AG, and Stryker Corporation.
North America held the dominating intracranial aneurysm during the analysis period of 2022 to 2030.
Asia-Pacific region exhibited fastest growing CAGR for intracranial aneurysm during the analysis period of 2022 to 2030.
Increasing incidence of a brain aneurysm, growing demand for minimally invasive procedures, and introduction of cutting-edge technical products, drives the growth of global intracranial aneurysm market.
Based on type, endovascular coiling segment is expected to hold the maximum share intracranial aneurysm market.